Matches in Wikidata for { <http://www.wikidata.org/entity/Q94317877> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q94317877 description "article scientifique publié en 2019" @default.
- Q94317877 description "wetenschappelijk artikel" @default.
- Q94317877 description "наукова стаття" @default.
- Q94317877 name "32.4 A NOVEL TREATMENT FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA BY ENHANCING THE ACTIVITY OF PARVALBUMIN INTERNEURONS" @default.
- Q94317877 name "32.4 A NOVEL TREATMENT FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA BY ENHANCING THE ACTIVITY OF PARVALBUMIN INTERNEURONS" @default.
- Q94317877 type Item @default.
- Q94317877 label "32.4 A NOVEL TREATMENT FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA BY ENHANCING THE ACTIVITY OF PARVALBUMIN INTERNEURONS" @default.
- Q94317877 label "32.4 A NOVEL TREATMENT FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA BY ENHANCING THE ACTIVITY OF PARVALBUMIN INTERNEURONS" @default.
- Q94317877 prefLabel "32.4 A NOVEL TREATMENT FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA BY ENHANCING THE ACTIVITY OF PARVALBUMIN INTERNEURONS" @default.
- Q94317877 prefLabel "32.4 A NOVEL TREATMENT FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA BY ENHANCING THE ACTIVITY OF PARVALBUMIN INTERNEURONS" @default.
- Q94317877 P1433 Q94317877-7961EA95-2F6D-413C-ACE2-6D8E9A64CAF1 @default.
- Q94317877 P1476 Q94317877-34249215-BB70-4F8F-B95F-A3FD0C8FE67E @default.
- Q94317877 P2093 Q94317877-33A86074-C719-4A16-A7F3-804140594390 @default.
- Q94317877 P2093 Q94317877-42875BCE-8947-4E27-AE98-8BF4A44B57A3 @default.
- Q94317877 P2093 Q94317877-4FAACBDC-0E97-45C1-9D4B-04A2C55AFE8A @default.
- Q94317877 P2093 Q94317877-8E7C1072-A973-4AD6-81D3-81A1C70731F8 @default.
- Q94317877 P2093 Q94317877-D8223230-9D9D-49C0-9DF5-89D2F2CE9E93 @default.
- Q94317877 P304 Q94317877-D779F0C3-58B5-46A9-90BE-0C4A4C64578B @default.
- Q94317877 P31 Q94317877-F9000DB3-D1E4-4C33-A9CE-E605A0DC3D6D @default.
- Q94317877 P356 Q94317877-C53C672C-B45A-4679-AE6D-74FEF59E06AE @default.
- Q94317877 P433 Q94317877-6D3DC149-76DE-40C5-9345-DE535D31F2B3 @default.
- Q94317877 P478 Q94317877-4CBA8639-EC45-4483-9FC9-1C5C1D9EE198 @default.
- Q94317877 P50 Q94317877-5BA4ABA1-1675-4D29-B2B7-3E676E8939ED @default.
- Q94317877 P577 Q94317877-AC69B4CC-8CE5-445F-A34B-404CC13C1192 @default.
- Q94317877 P921 Q94317877-01FDD7A9-AF57-4FC6-90DA-BBCA718FC8AF @default.
- Q94317877 P921 Q94317877-2DAD21D4-4AB7-4E70-B385-0EB53A9F0BD5 @default.
- Q94317877 P932 Q94317877-94361CC7-8741-40BB-9ACD-F7CFD645B926 @default.
- Q94317877 P356 SBZ022.135 @default.
- Q94317877 P1433 Q4049133 @default.
- Q94317877 P1476 "32.4 A NOVEL TREATMENT FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA BY ENHANCING THE ACTIVITY OF PARVALBUMIN INTERNEURONS" @default.
- Q94317877 P2093 "Charles Large" @default.
- Q94317877 P2093 "Frans van den Berg" @default.
- Q94317877 P2093 "John Hutchison" @default.
- Q94317877 P2093 "Oliver Howes" @default.
- Q94317877 P2093 "Tiago Reis Marques" @default.
- Q94317877 P304 "S142-S143" @default.
- Q94317877 P31 Q13442814 @default.
- Q94317877 P356 "10.1093/SCHBUL/SBZ022.135" @default.
- Q94317877 P433 "Suppl 2" @default.
- Q94317877 P478 "45" @default.
- Q94317877 P50 Q90141025 @default.
- Q94317877 P577 "2019-04-09T00:00:00Z" @default.
- Q94317877 P921 Q41112 @default.
- Q94317877 P921 Q57859955 @default.
- Q94317877 P932 "6455279" @default.